Durvalumab in combination with carboplatin and paclitaxel is indicated for the first-line treatment of adults with primary advanced or recurrent endometrial cancer who are candidates for systemic therapy
The iStent platform uses tiny surgical implants to lower eye pressure by restoring the eye’s natural fluid drainage system in patients with glaucoma
Lyfius Pharma restarts operations at Penicillin-G manufacturing facility
The approval in China is supported by a robust local clinical development program confirming the drug’s safety, tolerability, and efficacy profile
Granules India receives 1 observation from USFDA for Chantilly facility
Acquisition to be followed by merger; strengthens Torrent’s IPM market presence
Prucalopride Tablets are bioequivalent to Motegrity Tablets, 1 mg and 2 mg, of Takeda Pharmaceuticals USA
J B Chemicals and Pharmaceuticals receives ANDA approval for Amitriptyline Hydrochloride Tablets from USFDA
TEVIMBRA is a uniquely designed anti-PD-1 monoclonal antibody developed by BeiGene (now BeOne Medicines)
First and only TROP2-directed therapy approved in the US for the treatment of lung cancer
Subscribe To Our Newsletter & Stay Updated
